Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen Fei

Showing results (671-680 of 709) with videos related to

Pageof 71
Sort By:
The Lancet. Oncology|May 8, 2012
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysisNa Liu, Nian-Yong Chen, Rui-Xue Cui, et al.
JAMA Oncology|July 14, 2022
Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in ChinaHan Qiao, Xi-Rong Tan, Hui Li, et al.
EMBO Reports|May 9, 2026
roX1 and roX2 lncRNAs promote heterochromatinization in intestinal stem cells and impair longevityKai-Le Li, Chen Wang, Yong-Hao Li, et al.
Clinical Rheumatology|June 20, 2020
Associations of FKBP4 and FKBP5 gene polymorphisms with disease susceptibility, glucocorticoid efficacy, anxiety, depression, and health-related quality of life in systemic lupus erythematosus patientsQiu-Yue Lou, Zhen Li, Ying Teng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2026
Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER TrialsSai-Wei Huang, Ye-Lin Liang, Ya-Lan Tao, et al.
Radiology|August 26, 2025
MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk StratificationGuan-Jie Qin, Wei Jiang, Wu-Qi Zhang, et al.
Clinical and Translational Radiation Oncology|December 22, 2021
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patientsPierre Blanchard, Anne W M Lee, Alexandra Carmel, et al.
CA: a Cancer Journal for Clinicians|February 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trialLing-Long Tang, Lin Chen, Gui-Qiong Xu, et al.
Nature Communications|May 31, 2022
A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinomaYe-Lin Liang, Yuan Zhang, Xi-Rong Tan, et al.
Cancer Cell|July 26, 2024
Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON studyJiawei Lv, Ling-Xin Xu, Zhi-Xuan Li, et al.
Pageof 71

Showing results (671-680 of 709) with videos related to

Sort By:
Pageof 71
The Lancet. Oncology|May 8, 2012
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysisNa Liu, Nian-Yong Chen, Rui-Xue Cui, et al.
JAMA Oncology|July 14, 2022
Association of Intratumoral Microbiota With Prognosis in Patients With Nasopharyngeal Carcinoma From 2 Hospitals in ChinaHan Qiao, Xi-Rong Tan, Hui Li, et al.
EMBO Reports|May 9, 2026
roX1 and roX2 lncRNAs promote heterochromatinization in intestinal stem cells and impair longevityKai-Le Li, Chen Wang, Yong-Hao Li, et al.
Clinical Rheumatology|June 20, 2020
Associations of FKBP4 and FKBP5 gene polymorphisms with disease susceptibility, glucocorticoid efficacy, anxiety, depression, and health-related quality of life in systemic lupus erythematosus patientsQiu-Yue Lou, Zhen Li, Ying Teng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2026
Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER TrialsSai-Wei Huang, Ye-Lin Liang, Ya-Lan Tao, et al.
Radiology|August 26, 2025
MRI-based Middle Neck Involvement in Stage N1-N2 Nasopharyngeal Carcinoma: A Marker for Risk StratificationGuan-Jie Qin, Wei Jiang, Wu-Qi Zhang, et al.
Clinical and Translational Radiation Oncology|December 22, 2021
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patientsPierre Blanchard, Anne W M Lee, Alexandra Carmel, et al.
CA: a Cancer Journal for Clinicians|February 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trialLing-Long Tang, Lin Chen, Gui-Qiong Xu, et al.
Nature Communications|May 31, 2022
A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinomaYe-Lin Liang, Yuan Zhang, Xi-Rong Tan, et al.
Cancer Cell|July 26, 2024
Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON studyJiawei Lv, Ling-Xin Xu, Zhi-Xuan Li, et al.
Pageof 71